Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate.
about
Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesDecreased inducibility of TNF expression in lipid-loaded macrophagesDehydroepiandrosterone anti-atherogenesis effect is not via its conversion to estrogen.Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase.Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipidsRole of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium.Antioxidant: a new role for RU-486 and related compoundsEffect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoproteinThe necrotic venom of the brown recluse spider induces dysregulated endothelial cell-dependent neutrophil activation. Differential induction of GM-CSF, IL-8, and E-selectin expression.Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in miceLipids and atherosclerosis: clinical management of hypercholesterolaemia.Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromataRole of monocytes in atherogenesis.Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells.Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils.Adverse effects of hyperlipidemia on bone regeneration and strength.Lipoproteins modulate expression of the macrophage scavenger receptorProtective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.Protective role of heme oxygenase in the blood vessel wall during atherogenesis.Noninvasive assessment of preclinical atherosclerosis.Biological activity of the receptor for macrophage colony-stimulating factor in the human endometrial cancer cell line, Ishikawa.Novel vascular molecule involved in monocyte adhesion to aortic endothelium in models of atherogenesis.Activation of NF-κB in placentas of women with preeclampsia.Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability.Antioxidant activity of proteins and peptides.Anti-atherogenic effect of Humulus japonicus in apolipoprotein E-deficient mice.The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts.Wine polyphenols and promotion of cardiac health.Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesionHeterogeneous in vivo behavior of monocyte subsets in atherosclerosis.Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages.Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein.Mildly oxidized low-density lipoproteins suppress the proliferation of activated CD4+ T-lymphocytes and their interleukin 2 receptor expression in vitro.Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta1 integrin.Biochemistry and pathology of radical-mediated protein oxidation.Antiatherosclerotic Potential of Active Principle Isolated from Eugenia jambolana in Streptozotocin-Induced Diabetic Rats.Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque.Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques.
P2860
Q21296830-BDA672FE-1D07-4370-84D1-D11F2E8A2FDCQ24791561-264C98DC-E995-4901-8757-E7828E05D696Q33552190-9F5E5D51-2E5D-4245-8383-0EC816510727Q33760697-B4D7E4A0-A8CD-4984-B717-492DE000EC3CQ33784464-44698016-B3E2-4696-A2BA-14A2350526E4Q34157586-87370436-EC0E-4927-814F-2CC18753A0F1Q34157921-89F6E9E8-F83A-49D2-B170-CBBA0F11AD56Q34202226-CD522105-6AD2-4C28-BBE0-D82AAE9A714FQ34206300-7235BA0B-5D02-445E-8031-B58CC7FB51E1Q34228951-2C1A0040-0692-4D7E-8AC8-319A77F75AB6Q34229709-845C2DD6-74B7-4E94-BCFC-72F23D7EAB7CQ34240879-78F964F7-BAA8-4A5A-BF67-4857DEEF8088Q35251005-6719E086-1DB3-4905-A340-680E5DABB7C3Q35541858-DC4D2422-37AA-4466-8BF1-E27102DF0B31Q35553734-DA6004C7-390B-42FF-AB17-AC7B1D48B407Q35730371-C05EF5FA-CE31-4C54-8338-74DD850D53C9Q35742748-1452CD39-F366-41E3-9367-155EAB278BB9Q35765135-AD991E17-934F-421A-BC26-C5738D03F26FQ35768830-DABD533F-C5E2-4F4A-8EF3-034C74E8B424Q35794768-F2561E6C-EDD0-4606-AB57-6B2F6AE6D471Q36012908-070732EE-4359-4341-9634-36122F10292EQ36134660-2E5CF7B2-C6E1-4157-9209-B7140A262921Q36377355-41800DFC-7B7A-4145-A749-F6CB821CF5B3Q36525564-0BCC5CFD-BC11-48EC-9E01-95114F015184Q36725904-0311A6CF-2B6B-4732-99D2-2F18E3A0E748Q37157375-06003B50-53D4-4849-B69B-AE74540E2CA0Q37269970-2881DE6F-0536-4B6E-9EE5-805361A0409FQ37275296-3BC55F39-1532-4E2C-842D-AEF1A3688A65Q37350069-E094DAAE-B3AF-4712-81F2-F5712C5E5C10Q37353803-23FA39FC-6DD0-4B18-A378-75527A757B70Q37446568-29E39008-9FE8-4CFD-9AC4-73E9699ED881Q39766988-85833F6F-1122-4066-A3FD-DD2AA9FBFED2Q40643736-D0E4E663-6497-497D-815B-014BC4AF144EQ41051080-47021D57-A982-426E-A41D-8554F80BD48BQ41093059-E4DDAE33-2263-48EA-A50D-6AE470D88835Q41282843-BB27F03D-ADAA-433B-A79F-11DB47C92FF7Q41481967-8B6F2BAC-93FE-4A99-8F9E-E812EEC97421Q41998559-343B4A9C-E7B7-4EEE-B87C-FB9AA079B67FQ42991232-0B80CE71-9897-4D2E-85D2-43AC67AACA54Q43002718-DE698314-27CA-4D20-9909-8BEB7EB2DDF8
P2860
Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Minimally modified low density ...... yclic adenosine monophosphate.
@ast
Minimally modified low density ...... yclic adenosine monophosphate.
@en
Minimally modified low density ...... yclic adenosine monophosphate.
@nl
type
label
Minimally modified low density ...... yclic adenosine monophosphate.
@ast
Minimally modified low density ...... yclic adenosine monophosphate.
@en
Minimally modified low density ...... yclic adenosine monophosphate.
@nl
prefLabel
Minimally modified low density ...... yclic adenosine monophosphate.
@ast
Minimally modified low density ...... yclic adenosine monophosphate.
@en
Minimally modified low density ...... yclic adenosine monophosphate.
@nl
P2093
P2860
P921
P356
P1476
Minimally modified low density ...... yclic adenosine monophosphate.
@en
P2093
A Andalibi
A M Fogelman
J A Berliner
M C Territo
P2860
P304
P356
10.1172/JCI116590
P407
P577
1993-07-01T00:00:00Z